期刊文献+

氯胺酮为麻醉剂的MECT效果

MECT Effect of Ketamine as Anesthetics
下载PDF
导出
摘要 目的:探讨氯胺酮为麻醉剂的MECT效果.方法:将2017年4月-2019年4月于笔者所在医院进行MECT治疗的102例患者作为研究对象,按照随机数字法分为两组,对照组52例,观察组50例.对照组行丙泊酚麻醉,观察组行氯胺酮麻醉.对比两组临床指标及阳性与阴性症状量表(PANSS)评分,并记录治疗过程中不良反应情况.结果:治疗后,观察组抽搐能量指数为(15102±3305),低于对照组的(20001±3518),差异有统计学意义(P<0.05);观察组治疗后阳性及阴性因子评分分别为(12.25±3.12)、(16.74±4.25)分,均低于对照组的(18.71±3.87)、(24.89±7.79)分,差异均有统计学意义(P<0.05);观察组不良反应发生率为10.00%,低于对照组的59.62%,差异有统计学意义(P<0.05).结论:在进行MECT治疗过程中,氯胺酮与丙泊酚具有相近的麻醉效果,但前者能显著改善PANSS评分,且不良反应发生率低,安全性更高,值得在临床中推广使用. Objective:To study the MECT effect of Ketamine as anesthetics.Method:A total of 102 patients who were treated with MECT in our hospital from April 2017 to April 2019 were selected as the study objects and divided into two groups according to the random number method,52 cases in the control group and 50 cases in the observation group.The control group was given Propofol anesthesia and the observation group was given Ketamine anesthesia.Clinical indicators and positive and negative symptom scale(PANSS)scores of the two groups were compared,and the adverse reactions were recorded.Result:After treatment,the twitch energy index of the observation group was(15102±3305),which was lower than(20001±3518)of the control group,and the difference was statistically significant(P<0.05).After treatment,the scores of positive and negative factors of the observation group were(12.25±3.12),(16.74±4.25)points,which were lower than(18.71±3.87),(24.89±7.79)points of the control group,and the differences were statistically significant(P<0.05).The incidence of adverse reactions of the observation group was 10.00%,which was lower than 59.62%of the control group,and the difference was statistically significant(P<0.05).Conclusion:Ketamine and Propofol have similar anesthetic effect in MECT treatment,but the former can improve the PANSS score greatly,and the incidence of adverse reactions is lower and the safety is higher,which is worthy of clinical application.
作者 肖雁 郑小泳 梁丽卿 李娟花 黄钟展 XIAO Yan;ZHENG Xiaoyong;LIANG Liqing;LI Juanhua;HUANG Zhongzhan(Jiangmen Third People’s Hospital, Jiangmen 529000, China)
出处 《中外医学研究》 2020年第8期39-41,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
基金 广东省江门市卫生健康局2017年医疗卫生计划项目(项目编号:17A021)。
关键词 氯胺酮 麻醉剂 MECT Ketamine Anesthetics MECT
  • 相关文献

参考文献5

二级参考文献62

  • 1Mlrtensson B,Andersson G,Walinder J,et al.Depression treatment-then,now and in the future[J].Lakartidningen,2013,110(9-10):493-495.
  • 2Tang YL,Jiang W5 Ren YP,et al.Electroconvulsive therapy in China:clinical practice and research on efficacy[J].J ECT,2012,28(4):206-212.
  • 3Loo,C.,B.Simpson,R.Mac Pherson.Augmentation strategies in electroconvulsive therapy[J].The journal of ECT,2010,26(3):202-207.
  • 4Diazgranados N,Ibrahim L,Brutsche NE,et al.A randomized add-on trial of an N>methyl-D-aspartate antagonist in treatment-re sistant bipolar depression[J].Archives of general psychiatry,2010,67(8):793-802.
  • 5Aan Het Rot M,Zarate CA JR,Chamey DS,et al.Ketamine for depression:where do we go from here?[J].Biol Psychiatry,2012,72(7):537-547.
  • 6Zarate CA Jr,Singh JB,Carlson PJ,et al.A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression[J].Archives of general psychiatry,2006,63(8):856-864.
  • 7Zarate CA Jr,Mathews D,Ibrahim L,et al.A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression[J].Biol Psychiatry,2013,74(4):257-264.
  • 8Loo CK,Katalinic N,Garfield JB,et al.Neuropsychological and mood effects of ketamine in electroconvulsive therapy:a randomised controlled trial[J].J Affect Disord,2012,142(1-3):233-240.
  • 9Abdullah CG,Fasula M,Kelmendi B,et al.Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting[J].J ECT,2012,28(3):157-161.
  • 10Cowey J R,A N Crawford,D K Lowe.Intravenous ketamine for treatment-resistant major depressive disorder[J].Ann Pharmacother,2012,46(1):117-123.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部